BR0110232A - Vacina para mioencefalite equina causada por protozoário - Google Patents
Vacina para mioencefalite equina causada por protozoárioInfo
- Publication number
- BR0110232A BR0110232A BR0110232-0A BR0110232A BR0110232A BR 0110232 A BR0110232 A BR 0110232A BR 0110232 A BR0110232 A BR 0110232A BR 0110232 A BR0110232 A BR 0110232A
- Authority
- BR
- Brazil
- Prior art keywords
- protozoan
- vaccine
- myencephalitis
- equine
- derived therefrom
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/947—Microorganisms using protozoa
Abstract
"VACINA PARA MIOENCEFALITE EQuINA CAUSADA POR PROTOZOáRIO". A presente invenção fornece um componente imunogenicamente ativo que compreende células inativadas de Sarcocystis neurona e/ou células inativadas de Neospora hughesi; antígenos derivados das mesmas; DNA derivado das mesmas; ou uma mistura; ou em combinação com outros componentes de vacina das mesmas. São ainda fornecidas composições para vacinas úteis para a prevenção ou para a melhora da infecção e da doença mioencefalite causada por protozoários e um processo para a propagação da cultura de células de parasitas protozoários.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19943500P | 2000-04-25 | 2000-04-25 | |
US27869501P | 2001-03-26 | 2001-03-26 | |
PCT/US2001/040527 WO2001080885A2 (en) | 2000-04-25 | 2001-04-13 | Equine protozoal myeloencephalitis vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0110232A true BR0110232A (pt) | 2003-01-21 |
Family
ID=26894769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0110232-0A BR0110232A (pt) | 2000-04-25 | 2001-04-13 | Vacina para mioencefalite equina causada por protozoário |
Country Status (7)
Country | Link |
---|---|
US (2) | US7169398B2 (pt) |
EP (1) | EP1276499A2 (pt) |
AR (1) | AR035182A1 (pt) |
AU (1) | AU2001251761A1 (pt) |
BR (1) | BR0110232A (pt) |
CA (1) | CA2407517A1 (pt) |
WO (1) | WO2001080885A2 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0110232A (pt) * | 2000-04-25 | 2003-01-21 | Wyeth Corp | Vacina para mioencefalite equina causada por protozoário |
CN101596312A (zh) | 2002-05-21 | 2009-12-09 | 先灵-普劳有限公司 | 孢子纲物种体外培养的方法及其用途 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993010237A1 (en) * | 1991-11-12 | 1993-05-27 | Regents Of The University Of Minnesota | Recombinant vaccine against lyme disease |
JPH07507768A (ja) * | 1992-03-12 | 1995-08-31 | アルカーメス コントロールド セラピューティクス,インコーポレイテッド | Acth含有マイクロスフェアの制御放出 |
US6514697B1 (en) * | 1992-05-29 | 2003-02-04 | The Regents Of The University Of California | Methods for detection of Crytosporidium species and isolates and for diagnosis of Cryptosporidium infections |
US5538733A (en) * | 1994-07-07 | 1996-07-23 | Willmar Poultry Company, Inc. | Method of priming an immune response in a one-day old animal |
US6110665A (en) * | 1995-02-14 | 2000-08-29 | University Of Kentucky Research Foundation | Sarcocystis neuronadiagnostic primer and its use in methods of equine protozoal myeloencephalitis diagnosis |
GB2310212A (en) * | 1996-02-16 | 1997-08-20 | Jose Luis Azumendi | Isolation of the sarcocystine toxin from the genus Sarcocystis |
WO1997029120A1 (en) * | 1996-02-05 | 1997-08-14 | Sarco Research Corporation Limited | Sarcocystine isolation |
GB2310135A (en) * | 1996-02-16 | 1997-08-20 | Jose Luis Azumendi | Sarcocystis vaccine:lyophilized bradyzoites |
US5958414A (en) * | 1997-09-03 | 1999-09-28 | Heska Corporation | Composition to protect a mammal against Bartonella henselae infection |
US6071737A (en) * | 1998-03-16 | 2000-06-06 | The Regents Of The University Of California | Equine Neospora isolate and its uses |
US7163682B2 (en) * | 1998-04-13 | 2007-01-16 | The Forsyth Institute | Glucan binding protein and glucosyltransferase immunogens |
US7056517B2 (en) * | 1998-04-13 | 2006-06-06 | The Forsyth Institute | Glucosyltransferase immunogens |
US6153394A (en) | 1998-09-18 | 2000-11-28 | Board Of Trustees Operating Michigan State University | Immunoassay for equine protozoal myeloencephalitis in horses |
US6194408B1 (en) * | 1998-12-22 | 2001-02-27 | Bayer Corporation | Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma |
US6150361A (en) * | 1998-12-22 | 2000-11-21 | Bayer Corporation | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
AU3498200A (en) * | 1999-02-19 | 2000-09-04 | Michigan State University | An antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid |
US6737237B1 (en) * | 1999-05-04 | 2004-05-18 | Apicomplexan Therapeutics, Llc | Antimicrobial agents, diagnostic reagents, and vaccines based on unique Apicomplexan parasite components |
CA2382026A1 (en) * | 1999-09-02 | 2001-03-08 | Ruth A. Vrable | Vaccine to control equine protozoal myeloencephalitis in horses |
US20070172502A1 (en) * | 2000-02-07 | 2007-07-26 | David Bzik | Compositions and methods for treatment of Toxoplasma gondii and other apicomplexans |
BR0110232A (pt) * | 2000-04-25 | 2003-01-21 | Wyeth Corp | Vacina para mioencefalite equina causada por protozoário |
US7342101B1 (en) * | 2003-12-01 | 2008-03-11 | The University Of Texas System Board Of Regents | Compositions and methods comprising a protective antigen of Coccidiodes immitis |
-
2001
- 2001-04-13 BR BR0110232-0A patent/BR0110232A/pt not_active IP Right Cessation
- 2001-04-13 AU AU2001251761A patent/AU2001251761A1/en not_active Abandoned
- 2001-04-13 CA CA002407517A patent/CA2407517A1/en not_active Abandoned
- 2001-04-13 EP EP01925175A patent/EP1276499A2/en not_active Withdrawn
- 2001-04-13 WO PCT/US2001/040527 patent/WO2001080885A2/en active Application Filing
- 2001-04-17 AR ARP010101787A patent/AR035182A1/es unknown
- 2001-04-23 US US09/840,485 patent/US7169398B2/en not_active Expired - Fee Related
-
2006
- 2006-12-12 US US11/637,541 patent/US20070104739A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2407517A1 (en) | 2001-11-01 |
EP1276499A2 (en) | 2003-01-22 |
US7169398B2 (en) | 2007-01-30 |
US20020041886A1 (en) | 2002-04-11 |
AR035182A1 (es) | 2004-05-05 |
US20070104739A1 (en) | 2007-05-10 |
WO2001080885A3 (en) | 2002-02-21 |
AU2001251761A1 (en) | 2001-11-07 |
WO2001080885A2 (en) | 2001-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9801015A (pt) | Vacina de antìgeno de superfìcie contra gripe, e, processo para a preparação de proteìnas de antìgeno de superfìcie de vìrus de gripe preparados em uma cultura de célula animal. | |
BRPI0510928A (pt) | identificação de organismos viralmente infectados e vacinados | |
ES2156110T3 (es) | Analogos de sub-unidades de toxina del colera derivados de adn recombinante. | |
EA200900784A1 (ru) | Вакцины, включающие антиген из четырех штаммов вируса гриппа | |
DE69935211D1 (de) | Diagnosesysteme auf basis von kulturen gemischter zellen | |
BR9708387A (pt) | Processo para vacinação de um mamìfero a um antìgeno selecionado, células patogênica e hospedeira, composição de vacina, ácido nucleico, e, opsonina engenheirada. | |
BRPI0208301A8 (pt) | vacinas de ácido nucléico para prevenção de infecção por flavivírus | |
BRPI0415622A (pt) | linhas de células aviárias importalizadas para produção de vìrus | |
BR9913406A (pt) | Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção | |
BR0009157A (pt) | Vacina e antìgeno de staphylococcus | |
DK0861228T3 (da) | Lipopolyaminer som transfektionsmidler samt deres farmaceutiske anvendelser | |
BR0007230A (pt) | Agente condicionador para cabelos, claro, do tipo água-em-óleo de silicone | |
BR9814276A (pt) | Antìgenos de superfìcie | |
BRPI0208456B8 (pt) | métodos para cultura de circovírus | |
BR9909778A (pt) | Composição aquosa de xampu | |
BR0013771A (pt) | Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica | |
SE8703225L (sv) | Monoklonala antikroppar och peptider anvendbara vid behandling och diagnostisering av hiv-infektioner | |
BR9814432A (pt) | Composições derivadas de mycobacterium vaccae e processo para seu uso | |
BR0204920A (pt) | Uso de silicones aminados particulares em pré-tratamento de colorações diretas ou de oxidação de fibras queratìnicas e processo de coloração das mesmas | |
BR9610343A (pt) | Vacinas de subtipos múltiplos para fiv | |
BR0110232A (pt) | Vacina para mioencefalite equina causada por protozoário | |
BR0106558A (pt) | Dispositivo de limpeza para o corpo | |
BR0109164A (pt) | Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos | |
BR0209562A (pt) | Molécula de conjugado imunogênico, composição farmacêutica, método para preparar uma molécula de conjugado de polipeptìdeo-ácido hialurÈnico de baixo peso molecular, anticorpo purificado, métodos para eliciar uma resposta anticorpo em um mamìfero, e para inibir infecção estreptocócica em um mamìfero e a progressão de infecção em um mamìfero por bactérias contendo ha, e, kit de imunoensaio diagnóstico | |
Madera et al. | Toward the development of a one-dose classical swine fever subunit vaccine: antigen titration, immunity onset, and duration of immunity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012. |